BelHealth acquires Precision Toxicology

Healthcare-focused private equity firm BelHealth Investment Partners has acquired Precision Toxicology. Headquartered in San Diego, California, the company is a clinical laboratory that specializes in providing quantitative drug testing, primarily for the purpose of helping physicians monitor their patients undergoing treatment for pain or substance abuse.

DealsNorth AmericaUSBriefs